Cem Gabay - Concepedia

Author

Cem Gabay

University Hospital of Geneva ORCID

Also Known As

C GABAY, C Gabay, C. Gabay, Cem GABAY, Cem Gabay, Gabay, C, Gabay, C., Gabay, Cem, Mach, Francois, Makedonka Mitreva

476

Publications

37.2K

Citations

H-Index

146

Concepts

All Affiliations

University Hospital of Geneva University of Geneva Geneva College Hôpital Beau-Séjour University Hospital of Zurich

About

Cem Gabay is an author at University Hospital of Geneva specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	54	4.3K
2	Natural Sciences	4	4	134
3	Engineering	2	2	213
4	Health Sciences	2	2	170
5	Public Health	2	2	67

Cem Gabay

183

Publications

15.2K

Citations

H-Index

Page 1

	Year	Citations
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial Cem Gabay, Paul Emery, Ronald van Vollenhoven, The Lancet Rheumatoid DisorderRheumatologyAutoimmune DiseaseAllergyPhase 4	2013	664
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis Daniëlle M. Gerlag, Karim Raza, Lisa G. M. van Baarsen, Annals of the Rheumatic Diseases	2012	448
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs Josef S Smolen, R. B. M. Landewé, F. C. Breedveld, Annals of the Rheumatic Diseases Rheumatoid DisorderRheumatologyMedicinePsoriatic ArthritisBiological Therapy	2010	410
Prevotella copri in individuals at risk for rheumatoid arthritis D. Alpizar-Rodriguez, Till Robin Lesker, Achim Gronow, Annals of the Rheumatic Diseases	2019	409
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome Eric S. Weiss, Charlotte Girard, Dirk Holzinger, Blood	2018	381
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics Glynn Dennis, Cécile Holweg, Sarah Kummerfeld, Arthritis Research & Therapy	2014	361
Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis Nathalie Busso, Alexander So, Véronique Chobaz-Péclat, The Journal of Immunology	2002	326
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. Cem Gabay, Michael F. Smith, Denise M. Eidlen, Journal of Clinical Investigation InflammationSil-1ra MrnaCytokineAutoimmune DiseaseHepatology	1997	312
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells David Moulin, Olivier Donzé, Dominique Talabot‐Ayer, Cytokine InflammationCytokineMast Cell DisorderImmunologyImmune Regulation	2007	306
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis Gaby Palmer, Dominique Talabot‐Ayer, Céline Lamacchia, Arthritis & Rheumatism	2009	305

Page 1